Navigating Evidence Standards: Stakeholder Perspectives on External Controls and Randomization in Cancer Trials

Asia-Pacific Journal of Clinical Oncology · Published 2026-05-07 · DOI 10.1111/ajco.70120

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1111/ajco.70120

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications · European Journal of Cancer · 2026 · Cites or is cited by this article
• Larotrectinib in Adjuvant and First‐Line Treatment for Metastatic NTRK Fusion Colon Cancer · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• Mechanism of Astragalus Polysaccharides Regulating Ferroptosis and Inhibiting Malignant Progression of Ovarian Cancer Cells · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• Evolving Trends in Laryngeal Cancer Mortality in the United States, 1999–2024: A Population‐Based Analysis With Subgroup Stratified Trends through 2020 · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• Clinical–Pathologic Response Discordance After Neoadjuvant Therapy in Rectal Cancer and Its Prognostic Implications · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• Epstein‐Barr Virus‐positive NK/T‐cell Malignancies in Poland: Distinctive Features, Therapeutic Strategies, and Survival Insights—The Real‐world Retrospective Report of the Polish Lymphoma Research Group · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• Management of Adult Patients With Isocitrate Dehydrogenase‐Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro‐Oncology · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• Extranodal (Nasal Variant) NK/T ‐Cell Lymphoma of Head and Neck: Our Experience From a Tertiary Care Centre · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal
• Pan‐Cancer Analysis and Functional Characterization Identify SLC15A4 as a Novel Prognostic Biomarker and Therapeutic Target · Asia-Pacific Journal of Clinical Oncology · 2026 · Same journal